These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37555266)

  • 21. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline.
    McCall AL; Lieb DC; Gianchandani R; MacMaster H; Maynard GA; Murad MH; Seaquist E; Wolfsdorf JI; Wright RF; Wiercioch W
    J Clin Endocrinol Metab; 2023 Feb; 108(3):529-562. PubMed ID: 36477488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
    Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
    Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
    Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
    Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania.
    Mukama LJ; Moran A; Nyindo M; Philemon R; Msuya L
    Pediatr Diabetes; 2013 May; 14(3):211-6. PubMed ID: 23350587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-Induced Lipohypertrophy.
    Roy N; Mandal M
    N Engl J Med; 2024 Jun; 390(23):e60. PubMed ID: 38899697
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia.
    Torres Roldan VD; Urtecho M; Nayfeh T; Firwana M; Muthusamy K; Hasan B; Abd-Rabu R; Maraboto A; Qoubaitary A; Prokop L; Lieb DC; McCall AL; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2023 Feb; 108(3):592-603. PubMed ID: 36477885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 32. Type 1 Diabetes Mellitus and Lipohypertrophy - Impact of the Intervention on Glycemic Control via Patient's Examination and Retraining on Change of Infusion Set.
    Ucieklak D; Mrozińska S; Wojnarska A; Małecki MT; Klupa T; Matejko B
    Endocr Pract; 2023 Mar; 29(3):174-178. PubMed ID: 36581082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin related lipodystrophic lesions and hypoglycemia: Double standards?
    Gentile S; Strollo F; Della Corte T; Marino G; Guarino G
    Diabetes Metab Syndr; 2018 Sep; 12(5):813-818. PubMed ID: 29703450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
    Rossetti P; Porcellati F; Bolli GB; Fanelli CG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy.
    Yu J; Wang H; Zhu M; Yan D; Fan B; Shi Y; Shen M; Liu X; He W; Luo D; Xu J
    Chin Med J (Engl); 2021 Sep; 135(3):353-355. PubMed ID: 34561336
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat.
    Volkova NI; Davidenko IY
    Ter Arkh; 2019 May; 91(4):62-66. PubMed ID: 31094478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hundred-year experience with insulin and lipohypertrophy: An unresolved issue.
    Di Bartolo P; Eckel RH; Strollo F; Gentile S
    Diabetes Res Clin Pract; 2021 Aug; 178():108924. PubMed ID: 34153354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
    Ji J; Lou Q
    Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.